Cardlytics Q4 revenue down 8.4% to $82.5M; GAAP net loss $378.3M, guides Q1 weak

Cardlytics, Inc.

2024-FY EPS reported -$13.92 revenue$298,542,000

Q4 revenue $82.5M (-8.4% YoY); net loss $(378.3)M or $(11.32)/diluted share vs $(0.35) in Q4 2021.
Non-GAAP net loss $(9.7)M ($(0.29)/share) vs $(5.0)M ($(0.15)) in Q4 2021.
Adjusted EBITDA loss $(6.1)M vs positive $2.6M in Q4 2021; full year adjusted EBITDA loss $(45.2)M.
Q1 2023 guidance: revenue $54-63M, adjusted EBITDA loss $(17)-$(10)M.
Bridg ARR $23.1M (+51.3% YoY); MAUs 182.7M (+4.2%); ARPU $0.45 (-7.8%).

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Cardlytics, Inc. reported the first quarter of 2023 results: revenue $54.0 - $63.0. Guidance initiated.

Period: the first quarter of 2023
Revenue: $54.0 - $63.0
Guidance: initiated
Result: guidance update

Exact text from the filing

Cardlytics anticipates billings, revenue, and adjusted contribution to be in the following ranges (in millions): Q1 2023 Guidance Billings (1) $84.0 - $93.0 Revenue $54.0 - $63.0 Adjusted contribution (2) $26.0 - $31.0 Adjusted EBITDA (3) ($17.0) - ($10.0)

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Cardlytics, Inc. reported the fiscal year ended December 31, 2022 results: revenue $298.5 million, net income $(465.3) million, EPS $(13.92) per diluted share.

Period: the fiscal year ended December 31, 2022
Revenue: $298.5 million
Net income: $(465.3) million
EPS: $(13.92) per diluted share
Result: reported results

Exact text from the filing

Total revenue was $298.5 million, an increase of 11.8%, compared to $267.1 million in 2021. • Net loss attributable to common stockholders was $(465.3) million, or $(13.92) per diluted share, based on 33.4 million weighted-average common shares outstanding, compared to a net loss attributable to common stockholders of $(128.6) million, or $(3.99) per diluted share, based on 32.2 million weighted-average common shares outstanding in 2021.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Cardlytics, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $82.5 million, net income $(378.3) million, EPS $(11.32) per diluted share.

Period: the fourth quarter ended December 31, 2022
Revenue: $82.5 million
Net income: $(378.3) million
EPS: $(11.32) per diluted share
Result: reported results

Exact text from the filing

Total revenue was $82.5 million, a decrease of (8.4)%, compared to $90.0 million in the fourth quarter of 2021. • Net loss attributable to common stockholders was $(378.3) million, or $(11.32) per diluted share, based on 33.4 million weighted-average common shares outstanding, compared to a net loss attributable to common stockholders of $(11.8) million, or $(0.35) per diluted share, based on 33.4 million weighted-average common shares outstanding in the fourth quarter of 2021.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Cardlytics, Inc. filing history →

Source: SEC EDGAR

accession 0001666071-23-000026

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.